Lung Cancer

May 31, 2016May 31, 2016

Lung Metastasis in Mice Prevented by Targeting a Key Cancer Protein, Researchers Find

Lung Cancer, News

Researchers at Brown University demonstrated that controlling a key protein involved in cancer, through the activation of a specific immune response, can prevent cancer metastasis in mice’s lungs. The findings are described in ... Read more

May 26, 2016May 26, 2016

CPRIT Funds Two Lung Cancer Studies at MD Anderson with $10.6M

Lung Cancer, News

The Cancer Prevention and Research Institute of Texas (CPRIT) will fund two collaborative studies with $6 million and $4.6 million grants, for research targeting critical issues in lung cancer (LC) to be ... Read more

May 12, 2016May 13, 2016

Veracyte to Show Data on Lung Disease Genomic Classifiers at ATS 2016

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Veracyte, Inc. will present results at the American Thoracic Society (ATS) 2016 International Conference from multiple trials supporting the company’s genomic tests that may resolve uncertainty in lung disease diagnosis. The company ... Read more

May 3, 2016May 3, 2016

FDA Grants 510(k) Clearance for Lung Cancer Screening to Philips’ Early Detection CT Solutions

Lung Cancer, News

Amsterdam-based Royal Philips recently announced that any hospital or healthcare facility with one of the company’s computed tomography (CT) models will now be eligible to become a lung cancer screening center. ... Read more

April 29, 2016April 29, 2016

Lung Squamous Cell Carcinoma Phase 1/2 Trial to Assess Glembatumumab Vedotin Therapy

Lung Cancer, News

New Jersey-based Celldex Therapeutics recently announced the initiation of a Phase 1/2 clinical trial of glembatumumab vedotin in patients with squamous cell carcinoma. The study will focus on the safety and ... Read more

April 14, 2016April 14, 2016

Phase 3 Trial of Brigatinib for Non-Small Cell Lung Cancer Linked to ALK Mutations Is Launched by ARIAD

Lung Cancer, News

ARIAD Pharmaceuticals recently announced the start of a Phase 3 clinical trial of brigatinib for locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults with mutations in the anaplastic ... Read more

April 13, 2016April 13, 2016

Genentech’s Atezolizumab for Non-Small Cell Lung Cancer Gets FDA Nod for BLA and Priority Review

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application (BLA) and granted Priority Review for the company’s product atezolizumab for the treatment of locally advanced or ... Read more

April 12, 2016April 12, 2016

European Union Approves Giotrif (Afatinib) for Lung Squamous Cell Carcinoma

Lung Cancer, News

The European Union (EU) approved Giotrif (afatinib) on April 8 for the treatment of advanced squamous cell carcinoma (SqCC) of the lung in people for whom the disease has progressed despite treatment ... Read more

March 30, 2016March 30, 2016

Smokers Who Get Lung Cancer Screenings Should Also Be Encouraged to Quit, Researchers Say

Lung Cancer, News

Experts say smokers who visit a clinician for lung cancer screening should also be encouraged to quit smoking at their appointment, according to a recent article titled “Pairing smoking-cessation services with ... Read more

March 23, 2016March 23, 2016

Trinnovate Invests Heavily in VisionGate’s Lung Cancer Clinical Trials

Lung Cancer, News

Trinnovate Ventures recently announced it is partnering with VisionGate, a Phoenix-based company dedicated to improving diagnosis and treatment for lung cancer, to support the clinical trial programs for VisionGate’s LuCED (a ... Read more